Cheri Shute, CSW | |
1790 N State St, Orem, UT 84057-2025 | |
(801) 224-8255 | |
(801) 224-8301 |
Full Name | Cheri Shute |
---|---|
Gender | Female |
Speciality | Social Worker - Clinical |
Location | 1790 N State St, Orem, Utah |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1063004778 | NPI | - | NPPES |
4801785-3502 | Other | UT | DOBL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | 4801785-3502 (Utah) | Primary |
Mailing Address | Practice Location Address |
---|---|
Cheri Shute, CSW 1790 N State St, Orem, UT 84057-2025 Ph: (801) 224-8255 | Cheri Shute, CSW 1790 N State St, Orem, UT 84057-2025 Ph: (801) 224-8255 |
News Archive
Treatment with a commonly used drug slows the decline in lung function in patients with chronic obstructive pulmonary disease (COPD), according to results from the TORCH (TOwards a Revolution in COPD Health) study presented at the American Thoracic Society 2007 International Conference, on Tuesday, May 22.
U.S. researchers examined the genetic profiles of more than 1,100 urban children of different races, averaging around 3 years of age, and found that black children were more likely to have allergic antibodies to food allergens. The study also found that African ancestry was linked with levels of allergic antibodies to peanut typically associated with clinical peanut allergies.
A bi-partisan effort to decrease and prevent childhood obesity was introduced today in the Ohio Senate and Ohio House of Representatives, with the strong support of the Healthy Choices for Healthy Children coalition. The Healthy Choices for Healthy Children legislation is co-sponsored by Senator Kevin Coughlin (R-Cuyahoga Falls) and Senator Eric H. Kearney (D-Cincinnati) in the Ohio Senate.
Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, announced today that it has reached agreement with the United States Food and Drug Administration (FDA), under the Special Protocol Assessment (SPA) process, on the design of its planned Phase 3 study of its novel once-daily oral antibiotic Restanza to treat community acquired bacterial pneumonia (CABP). The trial is the first prospectively designed superiority study to be conducted in CABP.
› Verified 2 days ago
Katie Fishman, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 600 S Geneva Rd, Orem, UT 84059 Phone: 801-877-5300 | |
Alicia Hills, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 202 E 800 S Ste 105, Orem, UT 84058 Phone: 385-283-1032 | |
Morgan Oliphant, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1255 N 1200 W, Orem, UT 84057 Phone: 801-229-1181 | |
Rebecca Jane Mcnairy, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1125 W Center St, Orem, UT 84057 Phone: 801-903-5903 | |
Erin Elizabeth Vasquez, LCSW, RPT Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1255 N 1200 W, Orem, UT 84057 Phone: 801-229-1181 Fax: 801-229-2787 | |
Mr. Mark James Capell, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 313 E 1200 S, Suite 104, Orem, UT 84058 Phone: 801-377-1595 Fax: 801-377-1598 | |
Terry R Routt, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 570 E 1400 S, Orem, UT 84097 Phone: 801-426-6661 Fax: 801-426-6660 |